Investigation of Prevalence of cardiovascular involvement in patients with Covid-۱۹ disease admitted to Afzalipour Hospital in Kerman in ۲۰۱۹-۲۰۲۰

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 48

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-30-6_005

تاریخ نمایه سازی: 8 بهمن 1402

Abstract:

Background : Covid-۱۹ can acute cardiovascular syndrome. The aim of this study was to determine the frequency of cardiovascular involvement in patients with Covid-۱۹ disease .Methods:All patients who were diagnosed with Covid-۱۹ disease and were hospitalized and monitored due to disease conditions (stages ۲ and ۳) were eligible to enter the study. At the beginning of the patient's hospitalization, the patients' vital signs were recorded and the first ۱۲-lead ECG was taken. Patients then underwent cardiac monitoring. Patients underwent echocardiography during hospitalization. Preliminary tests including biochemistry, blood cell count, CRP and ESR and troponin were also performed for patients.Results:More than half of these patients are men. There was a significant relationship between Sinus.tach and history of heart disease (p = ۰.۰۲). The relationship between atrial fibrillation and history of heart disease was significant (p = ۰.۰۲). Nonspecific variable was also significantly associated with a history of heart disease (p = ۰.۰۴). Studies showed that ejection fraction was normal in ۸۷.۷% of patients and severe in ۵.۵%. There was a significant relationship between diastolic dysfunction grade and the history of heart disease (p = ۰.۰۲).Conclusion:The average age of patients with Covid-۹ is ۶۳.۵۵%, ۲۰.۲% of people with a history of heart disease,Due to the sensitivity of the subject, the presence of underlying diseases,can increase the risk of Covid-۱۹ disease and also increase the mortality rate of this disease in these. Therefore, it is suggested that more attention, priority in vaccinating against this disease in people with underlying diseases.

Authors

maryam maryam aliramezani

Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Amin Mahdavi

Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

mahshid ghanbarnejad

Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

mohammadjavad zarrabi

Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Sarehossadat Ebrahimi

Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Maedeh Jafari

Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran